Summary
Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level.
The global Lactulose market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:
Key Companies:
Abbott
Morinage
Milei
Inalco
Fresenius Kabi
Relax
Biofac
Dandong Kangfu
Key Types
Crystalline Lactulose
Liquid Lactulose
Key End-Use
Pharmaceuticals
Food Ingredient
Others
This report can be dispatched within 24-48 Hours.